Milestone Pharmaceuticals Inc. (MIST) Financials

MIST Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 87.1 million 58.6 million
2023-06-30 97.0 million 56.6 million
2023-03-31 111.1 million 57.1 million
2022-12-31 74.5 million 8.1 million

MIST Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.2 million 2.9 million
2023-06-30 -10.6 million 2.5 million
2023-03-31 -13.9 million 2.3 million
2022-12-31 -13.0 million 2.1 million

MIST Net Income

No data available :(

MIST Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 75.7 million - 2.1 million
2023-06-30 87.6 million 48.1 million 2.3 million
2023-03-31 101.0 million 47.3 million 2.4 million
2022-12-31 64.6 million - 2.5 million

MIST Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 43.0 million
2023-06-30 42.9 million
2023-03-31 42.9 million
2022-12-31 42.8 million

MIST Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 18000 6.7 million 4.2 million 4.4 million
2023-06-30 31000 8.6 million 4.4 million 3.4 million
2023-03-31 32000 10.3 million 3.9 million 2.4 million
2022-12-31 110000 10.6 million 4.1 million 2.6 million

MIST Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 23999
2023-06-30 - 24000
2023-03-31 1.0 million 18000
2022-12-31 3.5 million 406000

MIST

Price: $1.74

52 week price:
1.33
4.49

Earnings Per Share: -1.39 USD

P/E Ratio: -1.13

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 563278

Market Capitalization: 90.1 million

Links: